Lead Sponsor

Sanofi

Age

15 - No limit years

Sex

ALL

Healthy Volunteers

No

•Participants referred for the first time for splenomegaly exploration defined as :
•* Either a palpable mass on left upper abdominal quadrant, further confirmed by a ≥ 13 cm craniocaudal length on abdominal Imaging
•* Or a non palpable splenomegaly discovered on abdominal imaging and with a craniocaudal length ≥ 13 cm
•Participants with splenomegaly (as defined above) of unknown origin

•Participants with obvious diagnostics based on clinical exam, patient's interview and the previous initial routine biological tests :
•* Diagnosis of portal hypertension
•* Diagnosis of hemolytic anemia
•* Diagnosis of hematological malignancy
•* Known diagnosis of Gaucher Disease
•The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.